RNA delivery by extracellular vesicles in mammalian cells and its applications
By Killian O’Brien, K. Breyne, S. Ughetto, L. Laurent, X. Breakefield. Nature reviews. Molecular cell biology, 2020
1,459 citations recorded by the source corpus.
The term ‘extracellular vesicles’ refers to a heterogeneous population of vesicular bodies of cellular origin that derive either from the endosomal compartment (exosomes) or as a result of shedding from the plasma membrane (microvesicles, oncosomes and apoptotic bodies). Extracellular vesicles carry a variety of cargo, including RNAs, proteins, lipids and DNA, which can be taken up by other cells, both in the direct vicinity of the source cell and at distant sites in the body via biofluids, and elicit a variety of phenotypic responses. Owing to their unique biology and roles in cell–cell communication, extracellular vesicles have attracted strong interest, which is further enhanced by their potential clinical utility. Because extracellular vesicles derive their cargo from the contents of the cells that produce them, they are attractive sources of biomarkers for a variety of diseases. Furthermore, studies demonstrating phenotypic effects of specific extracellular vesicle-associated cargo on target cells have stoked interest in extracellular vesicles as therapeutic vehicles. There is particularly strong evidence that the RNA cargo of extracellular vesicles can alter recipient cell gene expression and function. During the past decade, extracellular vesicles and their RNA cargo have become better defined, but many aspects of extracellular vesicle biology remain to be elucidated. These include selective cargo loading resulting in substantial differences between the composition of extracellular vesicles and source cells; heterogeneity in extracellular vesicle size and composition; and undefined mechanisms for the uptake of extracellular vesicles into recipient cells and the fates of their cargo. Further progress in unravelling the basic mechanisms of extracellular vesicle biogenesis, transport, and cargo delivery and function is needed for successful clinical implementation. This Review focuses on the current state of knowledge pertaining to packaging, transport and function of RNAs in extracellular vesicles and outlines the progress made thus far towards their clinical applications. Extracellular vesicles transfer a variety of cellular components between cells — including proteins, lipids and nucleic acids. There is now evidence indicating that these cargoes, in particular RNAs, can affect the function of recipient cells. Extracellular vesicles are now being actively tested as biomarkers and delivery vehicles for therapeutic agents.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/a6f6f1aded4cf0a055d7468814b913d508fa190d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- G. Raposo
- Guillaume van Niel
- P. Vader
- Aled Clayton
- C. Théry
- T. Whiteside
- Marina Colombo
- Raghu Kalluri
In Molecular Biology
Citations in the corpus
- Challenges and directions in studying cell–cell communication by extracellular vesicles (2022, background): “The sorting of specific sets of mRNA and miRNA appears to depend on recognition of specific sequence in genetic material by RNA binding proteins (RBP) (reviewed in 16 ) and the generation of phase separated condensates of miRNA and RBP into processing bodies [G] 17 .”
- mRNA-based therapeutics: powerful and versatile tools to combat diseases (2022, background): “Other mRNA delivery systems Other types of vectors were developed to deliver mRNA, including protamine-condensed mRNA, exosomes, extracellular vesicles (EVs), mesoporous silica, CaP and so on.(190) Reactive astrocytederived exosomes were used to deliver MGMT mRNA to MGMTnegative glioma cells and inh”
- Clinical applications of stem cell-derived exosomes (2024, background): “69 From the perspective of an exosomal miRNA, one group discovered that miR-136-5p from bone marrow MSC-derived exosomes promoted osteoblast proliferation and differentiation in vitro, thereby promoting fracture healing in vivo.”